Terrain

Astellas’s and Pfizer’s cancer drug gets new product label data

Astellas Pharma and Pfizer have announced the FDA approved a supplemental New …

Bristol-Myers Squibb and bluebird bio Announce Positive Top-line Results from the Pivotal Phase 2 KarMMa Study of Ide-cel in Relapsed and Refractory Multiple Myeloma December 6, 2019
Arrowhead Pharmaceuticals Closes Underwritten Public Offering with Gross Proceeds of $266.8 Million December 6, 2019
Jasper Therapeutics Launches with $35 Million Series A Financing to Develop and Commercialize Innovative Conditioning Agents and Therapies to Transform Curative Hematopoietic Cell Transplants December 6, 2019
BioDuro Welcomes New President, Global CMC Solutions December 6, 2019
Alpha Holdings Urges OncoSec Stockholders to Vote Against China Grand Takeover Proposal at Special Meeting of Stockholders December 6, 2019
Global Antidiarrhoeals Drugs Market Report 2020 – ResearchAndMarkets.com December 6, 2019
Bristol-Myers Squibb and Acceleron Pharma Provide Update on FDA Advisory Committee for Reblozyl® (luspatercept-aamt) December 6, 2019